| Financial Year |
March 31 2023 |
| Monetary Funds |
464,515,884.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
12,909,060.40 |
| Advances to Suppliers |
129,552,049.38 |
| Other Receivables |
16,900,916.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
423,322,069.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,668,717.10 |
| Total Current Assets |
1,075,868,696.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
72,067,532.22 |
| Investment Properties |
87,083,304.00 |
| Fixed Assetes |
207,104,161.51 |
| Under-construction Projects |
268,240,231.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,810,390.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,711,657.29 |
| Deferred Income Tax Assets |
36,142,624.62 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
772,881,271.14 |
| Total Assets |
1,848,749,967.87 |
| Short-Term Loans |
220,899,583.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
96,723,846.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,845,875.56 |
| Taxes Payable |
70,469,466.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
487,200,619.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,980,588.24 |
| Other Current Liabilities |
28,266,157.94 |
| Sub-Total of Current Liabilities |
1,147,619,948.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,946,528.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,893,926.60 |
| Total Liabilities |
1,178,513,875.07 |
| Paid-In Capital(Or Share Stock) |
334,469,431.00 |
| Capital Surplus |
131,835,054.32 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
94,717,950.96 |
| Minority Stockholder's Interest |
123,384,795.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
546,851,297.11 |
| Owner's Equity（Stockholder's Equity） |
670,236,092.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,848,749,967.87 |
